Albumin-Based Drug Delivery Systems
Albumin is playing an increasing role as a versatile, biodegradable drug carrier in clinical theranostics. By applying different techniques, smart drug-delivery systems can be developed from albumin in order to improve drug delivery of different active pharmaceutical ingredients, even small-molecule...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2022. |
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 electronic resource (162 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993544665004498 |
---|---|
ctrlnum |
(CKB)5720000000008294 (oapen)https://directory.doabooks.org/handle/20.500.12854/84432 (EXLCZ)995720000000008294 |
collection |
bib_alma |
record_format |
marc |
spelling |
Albumin-Based Drug Delivery Systems Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2022. 1 electronic resource (162 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Open access Unrestricted online access star Albumin is playing an increasing role as a versatile, biodegradable drug carrier in clinical theranostics. By applying different techniques, smart drug-delivery systems can be developed from albumin in order to improve drug delivery of different active pharmaceutical ingredients, even small-molecule drugs, peptides or enzymes. Principally, three drug delivery technologies can be distinguished for binding small-molecule or peptide drugs through the charged amino acids, carboxyl, and amino groups of albumin: physical or covalent binding of the drug to albumin through a ligand- or protein-binding group, the fusion of drug with albumin or the encapsulation of drugs into albumin nanoparticles. The accumulation of albumin in inflamed tissues and solid tumours forms the rationale for developing albumin-based drug delivery systems for targeted drug delivery. Besides tumour therapy, albumin-based drug delivery systems can be successfully applied as anti-inflammatory and anti-thrombotic coating for medical devices. The development and optimization of albumin nanoparticles may also be a rational and promising tool for conventional or alternative administration routes in order to improve therapy. This collection provides an overview of the significant scientific research works in this field, which may inspire researchers towards further development and utilization of these smart drug delivery systems. English Medicine. plasma half-life extension albumin conjugation in vivo glucose-lowering activity glucagon-like peptide-1 quality by design rapid equilibrium dialysis muco-adhesion brain PAMPA RPMI 2650 nasal epithelial cell human serum albumin dimerization doxorubicin enhanced permeability and retention effect antitumor Arthrobacter globiformis gout half-life extension inverse electron demand Diels-Alder reaction site-specific albumin conjugation thermostability urate oxidase albumin anti-thrombotic CD39 coating of medical devices stent coating therapeutic fusion protein conjugates vanadium cancer prodrug hydrogels EPR/ESR spectroscopy release behavior disulfide glioma conjugate albumin binding moieties peptides Evans blue 4-(p-iodophenyl)butyric acid integrin αvβ6 integrin αvβ6 binding peptide improved pharmacokinetics PET imaging 3-0365-4108-X 3-0365-4107-1 Katona, Gábor. editor. |
language |
English |
format |
eBook |
author2 |
Katona, Gábor. |
author_facet |
Katona, Gábor. |
author2_variant |
g k gk |
author2_role |
TeilnehmendeR |
title |
Albumin-Based Drug Delivery Systems |
spellingShingle |
Albumin-Based Drug Delivery Systems |
title_full |
Albumin-Based Drug Delivery Systems |
title_fullStr |
Albumin-Based Drug Delivery Systems |
title_full_unstemmed |
Albumin-Based Drug Delivery Systems |
title_auth |
Albumin-Based Drug Delivery Systems |
title_new |
Albumin-Based Drug Delivery Systems |
title_sort |
albumin-based drug delivery systems |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute, |
publishDate |
2022 |
physical |
1 electronic resource (162 pages) |
isbn |
3-0365-4108-X 3-0365-4107-1 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT katonagabor albuminbaseddrugdeliverysystems |
status_str |
n |
ids_txt_mv |
(CKB)5720000000008294 (oapen)https://directory.doabooks.org/handle/20.500.12854/84432 (EXLCZ)995720000000008294 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Albumin-Based Drug Delivery Systems |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796651970955575296 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03912nam-a2200841z--4500</leader><controlfield tag="001">993544665004498</controlfield><controlfield tag="005">20231214133428.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202206s2022 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5720000000008294</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/84432</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995720000000008294</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="b">eng</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Albumin-Based Drug Delivery Systems</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (162 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="a">Open access</subfield><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Albumin is playing an increasing role as a versatile, biodegradable drug carrier in clinical theranostics. By applying different techniques, smart drug-delivery systems can be developed from albumin in order to improve drug delivery of different active pharmaceutical ingredients, even small-molecule drugs, peptides or enzymes. Principally, three drug delivery technologies can be distinguished for binding small-molecule or peptide drugs through the charged amino acids, carboxyl, and amino groups of albumin: physical or covalent binding of the drug to albumin through a ligand- or protein-binding group, the fusion of drug with albumin or the encapsulation of drugs into albumin nanoparticles. The accumulation of albumin in inflamed tissues and solid tumours forms the rationale for developing albumin-based drug delivery systems for targeted drug delivery. Besides tumour therapy, albumin-based drug delivery systems can be successfully applied as anti-inflammatory and anti-thrombotic coating for medical devices. The development and optimization of albumin nanoparticles may also be a rational and promising tool for conventional or alternative administration routes in order to improve therapy. This collection provides an overview of the significant scientific research works in this field, which may inspire researchers towards further development and utilization of these smart drug delivery systems.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicine.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">plasma half-life extension</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">albumin conjugation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in vivo glucose-lowering activity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glucagon-like peptide-1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">quality by design</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rapid equilibrium dialysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">muco-adhesion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">brain PAMPA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">RPMI 2650 nasal epithelial cell</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">human serum albumin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dimerization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">doxorubicin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">enhanced permeability and retention effect</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antitumor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Arthrobacter globiformis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gout</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">half-life extension</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inverse electron demand Diels-Alder reaction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">site-specific albumin conjugation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">thermostability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">urate oxidase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">albumin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anti-thrombotic</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CD39</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">coating of medical devices</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">stent coating</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">therapeutic fusion protein</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">conjugates</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vanadium</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prodrug</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogels</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">EPR/ESR spectroscopy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">release behavior</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">disulfide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glioma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">conjugate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">albumin binding moieties</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">peptides</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Evans blue</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">4-(p-iodophenyl)butyric acid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">integrin αvβ6</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">integrin αvβ6 binding peptide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">improved pharmacokinetics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PET imaging</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-4108-X</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-4107-1</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Katona, Gábor.</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:53:49 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-07-02 22:45:44 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337712050004498&Force_direct=true</subfield><subfield code="Z">5337712050004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337712050004498</subfield></datafield></record></collection> |